373 related articles for article (PubMed ID: 21892161)
1. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
Bass AJ; Lawrence MS; Brace LE; Ramos AH; Drier Y; Cibulskis K; Sougnez C; Voet D; Saksena G; Sivachenko A; Jing R; Parkin M; Pugh T; Verhaak RG; Stransky N; Boutin AT; Barretina J; Solit DB; Vakiani E; Shao W; Mishina Y; Warmuth M; Jimenez J; Chiang DY; Signoretti S; Kaelin WG; Spardy N; Hahn WC; Hoshida Y; Ogino S; DePinho RA; Chin L; Garraway LA; Fuchs CS; Baselga J; Tabernero J; Gabriel S; Lander ES; Getz G; Meyerson M
Nat Genet; 2011 Sep; 43(10):964-968. PubMed ID: 21892161
[TBL] [Abstract][Full Text] [Related]
2. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract][Full Text] [Related]
3. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.
Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI
PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966
[TBL] [Abstract][Full Text] [Related]
4. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
5. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.
Meyer MB; Goetsch PD; Pike JW
Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803
[TBL] [Abstract][Full Text] [Related]
6. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
8. Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.
Zhu C; Yamaguchi K; Ohsugi T; Terakado Y; Noguchi R; Ikenoue T; Furukawa Y
Cancer Sci; 2017 Apr; 108(4):612-619. PubMed ID: 28117551
[TBL] [Abstract][Full Text] [Related]
9. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.
Kendziorra E; Ahlborn K; Spitzner M; Rave-Fränk M; Emons G; Gaedcke J; Kramer F; Wolff HA; Becker H; Beissbarth T; Ebner R; Ghadimi BM; Pukrop T; Ried T; Grade M
Carcinogenesis; 2011 Dec; 32(12):1824-31. PubMed ID: 21983179
[TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
13. Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence.
Zhang M; Tang M; Fang Y; Cui H; Chen S; Li J; Xiong H; Lu J; Gu D; Zhang B
Int J Cancer; 2018 Feb; 142(3):498-513. PubMed ID: 28949031
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
15. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase.
Berry WL; Kim TD; Janknecht R
Int J Oncol; 2014 Apr; 44(4):1341-8. PubMed ID: 24481461
[TBL] [Abstract][Full Text] [Related]
18. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
19. Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.
Kundu S; Ali MA; Handin N; Padhan N; Larsson J; Karoutsou M; Ban K; Wiśniewski JR; Artursson P; He L; Hellström M; Sjöblom T
Genome Med; 2018 Jan; 10(1):2. PubMed ID: 29301589
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
